Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
32.66
-0.72 (-2.16%)
Mar 6, 2026, 9:36 AM EST - Market open
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.20 billion as of March 6, 2026. Its market cap has increased by 24.86% in one year.
Market Cap
2.20B
Enterprise Value
-1.26B
1-Year Change
24.86%
Ranking
Category
Stock Price
$32.66
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.20B, an increase of 17.87%. That is a compound annual growth rate of 1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.20B | 2.08% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 2.39B |
| Immunome | 2.37B |
| Disc Medicine | 2.30B |
| Tango Therapeutics | 2.27B |
| Ocular Therapeutix | 2.25B |
| Maze Therapeutics | 2.18B |
| Zai Lab | 2.16B |
| Mineralys Therapeutics | 2.11B |